VEGFB and myeloid sarcoma: Additionally, the multivariate analysis for the development of the MS components (Table 4) reported that VEGFb categories were significantly associated with the new onset of abdominal obesity by ATP-III criteria, where subjects with Low_VEGFb category had a 7-fold increased probability of developing abdominal obesity than those with High_VEGFb category; however, when IDF criteria for abdominal obesity diagnosis were considered, the differences did not reach significance.